Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by rcash1on Feb 15, 2018 9:30am
106 Views
Post# 27563908

RE:Focused long. But...

RE:Focused long. But...
LANk655 wrote:
is it a reality that Lib could be bought out before licensing? Or shortly after by a big dog? I'm hoping it's at least 2$ before that comes up but Hey, who really knows right!? Is it the investors best interest to be bought out short term (I'm not on this one) Or long term? Who do you think would buy them up? Along the lines of abcn, weed, ? Ideas? Cheers


I  personally don't see a a buy out coming short term . Unless somebody throwing cash around comes sniffing. For the right price anything is available. Only companies with enough cash for a buyout presently are  CGC , ACB , APH . Although there's a few companies with enough $ in treasury for a down payment  + shares or equity take . I really hope license is received sooner then later for this reason . Valuations from being de risked will rise this SP . As long as they keep the dilution down/ just complete what's planned ,this should be a 200 million Cap in shorter term future . That would equate to just under 2$ a share SP . Right now HVT or IMh are the cheapest caps with a sales license and their caps are around 150 million other then BE . It's under 100 million but no sales license and CBW had a large equity + supply take from BE . Just my thoughts 
<< Previous
Bullboard Posts
Next >>